FormWeb • brentuximab vedotin

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

brentuximab vedotin

brentuximab vedotin

Restricted Anti-Neoplastic Formulary
Restricted Adcetris --> Restricted to outpatient with administration approval.

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Adcetris	POWDER FOR INJECTION, INTRAVENOUS	50 mg

VIEW MORE Antineoplastic Agents
CLASS

Comments:

Restricted to oncology use in outpatient setting with approval from pharmacy administration required. Each case will be evaluated on an individual basis.

Reviewed: May 22, 2012

Last updated: Mar. 5, 2025

brentuximab vedotin

Black Box Warning: Progressive Multifocal Leukoencephalopathy (PML)
HAZ-MED: Table 1

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.